| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Moleculin Biotech, Inc. (MBRX) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. MBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.21M | $6.55M | - | |
| CFO | 1.62M | $3.30M | - | |
| Other | 295.5K | $602.8K | - | |
| Dir | 165.3K | $337.3K | - | |
| Dir | 165.3K | $337.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2017 | Klemp Walter V | Chief Executive Officer | Buy | 12,000 | $0.81 | $9,720.00 | +1.1% | |
| May 5, 2017 | Northcut Jacqueline | Director | Buy | 1,000 | $0.82 | $820.00 | New | |
| Apr 28, 2017 | George Robert E. | Director | Buy | 1,000 | $0.94 | $938.40 | New | |
| Apr 25, 2017 | Foster Jonathan P. | Exec. Vice President &CFO | Buy | 10,000 | $0.86 | $8,649.00 | New |